Breaking News Instant updates and real-time market news.

RAD

Rite Aid

$1.64

0.03 (1.87%)

08:55
05/15/18
05/15
08:55
05/15/18
08:55

Rite Aid to hold a business news update webcast

Management and Albertsons Companies discuss the strategic and financial benefits of the proposed merger transaction between the two companies on a webcast being held on May 15 at 9 am. Webcast Link

  • 15

    May

RAD Rite Aid
$1.64

0.03 (1.87%)

04/30/18
LOOP
04/30/18
NO CHANGE
Target $4
LOOP
Hold
Fred's CEO resignation 'fire but no sale,' says Loop Capital
In a research note titled "CEO resigns - Fire but no sale," Loop Capital analyst Andrew Wolf notes that Fred's (FRED) has announced the resignation of Chief Executive Officer Michael Bloom, effective as of April 24, 2018. Joseph Anto, Fred's Executive Vice President and Chief Financial Officer, will serve as Interim Chief Executive Officer. Additionally, the analyst points out that Alden Capital owns 24% of Fred's shares and its President, Heath Freeman, is now Chairman of the Board of Fred's. According to Freeman in a press release, "After the Company was not able to purchase certain assets from the Rite Aid Corporation (RAD)...the timing was right, both for Mike [Bloom] and the Company, for him to step down." Wolf reiterates a Hold rating and $4 price target on Fred's shares.
04/17/18
MZHO
04/17/18
NO CHANGE
MZHO
Amazon news removes 'unprecedented overhang' on drug sellers, says Mizuho
After CNBC reported yesterday afternoon that Amazon (AMZN) has decided to shelve its plan to sell and distribute pharmaceutical products, Mizuho analyst Ann Hynes said she had thought Amazon's current logistics and distribution model would not translate into healthcare. However, based on conversations with investors, she believes the magnitude of the overhang that Amazon presented for drug distributors and retail pharmacies was "unprecedented." While drug pricing is still a concern, she notes that the CNBC report removes one overhang on the drug supply chain stocks. Hynes remain a buyer of CVS Health (CVS) and Walgreens (WBA) and keeps Neutral ratings on Rite Aid (RAD) as well as on drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK).
04/13/18
COWN
04/13/18
NO CHANGE
Target $3
COWN
Outperform
Rite Aid appears undervalued at current levels, says Cowen
Cowen analyst Charles Rhyee noted Rite Aid reported better than expected EBITDA due to better than expected results in Pharmacy. The analyst said its guidance should provide investors with greater confidence of the company meeting its pro-forma targets, which validates his view that the shares appear undervalued. Rhyee reiterated his Outperform rating and $2.50 price target on Rite Aid shares.
02/20/18
EVER
02/20/18
NO CHANGE
Target $1.5
EVER
Underperform
Rite Aid transaction valued at 75c-$1.75 per share, says Evercore ISI
Evercore ISI analyst Ross Muken estimates the value per Rite Aid share to be 75c- $1.75 depending on the elections made by Rite Aid shareholders under the company's announced agreement with Albertson's. His estimate is based on the pro-forma company's "potentially generous" $3.7 B in EBITDA at an EV/EBITDA multiple of 6.8x, he explains. Muken keeps an Underperform rating on Rite Aid with a $1.50 price target. In early trading, Rite Aid shares are up 3c, or 1.6%, to $2.16.

TODAY'S FREE FLY STORIES

VKTX

Viking Therapeutics

$19.47

9.07 (87.21%)

08:28
09/19/18
09/19
08:28
09/19/18
08:28
Recommendations
Viking Therapeutics analyst commentary  »

Viking Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ZEAL

Zealand Pharma

$18.48

0.4 (2.21%)

, NVO

Novo Nordisk

$47.44

-0.2 (-0.42%)

08:27
09/19/18
09/19
08:27
09/19/18
08:27
Recommendations
Zealand Pharma, Novo Nordisk analyst commentary  »

Zealand Pharma price…

ZEAL

Zealand Pharma

$18.48

0.4 (2.21%)

NVO

Novo Nordisk

$47.44

-0.2 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$83.89

-1.82 (-2.12%)

08:26
09/19/18
09/19
08:26
09/19/18
08:26
Downgrade
Westlake Chemical rating change  »

Westlake Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLK

Allakos

$44.88

0.95 (2.16%)

08:25
09/19/18
09/19
08:25
09/19/18
08:25
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SPWR

SunPower

$7.55

0.97 (14.74%)

, ENPH

Enphase Energy

$4.35

0.48 (12.40%)

08:24
09/19/18
09/19
08:24
09/19/18
08:24
Recommendations
SunPower, Enphase Energy, First Solar analyst commentary  »

Tariff exemption a…

SPWR

SunPower

$7.55

0.97 (14.74%)

ENPH

Enphase Energy

$4.35

0.48 (12.40%)

FSLR

First Solar

$49.56

1.81 (3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

08:23
09/19/18
09/19
08:23
09/19/18
08:23
Conference/Events
JPMorgan to hold a summit »

India Investor Summit…

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
09/19/18
09/19
08:21
09/19/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
09/19/18
09/19
08:20
09/19/18
08:20
General news
Senate Judiciary vote on Kavanaugh Supreme Court vote cancelled, CNN reports »

The Senate Judiciary…

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$69.82

0.3 (0.43%)

, ZS

Zscaler

$39.79

-0.455 (-1.13%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Conference/Events
William Blair to hold a tour »

Cybersecurity Bus Tour…

OKTA

Okta

$69.82

0.3 (0.43%)

ZS

Zscaler

$39.79

-0.455 (-1.13%)

PANW

Palo Alto Networks

$234.07

2.1 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 06

    Dec

  • 10

    Dec

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$207.47

0.89 (0.43%)

08:20
09/19/18
09/19
08:20
09/19/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
09/19/18
09/19
08:20
09/19/18
08:20
General news
U.S. housing starts preview: »

U.S. housing starts…

08:20
09/19/18
09/19
08:20
09/19/18
08:20
General news
U.S. current account preview: »

U.S. current account…

XLK

Technology Select Sector SPDR

$74.46

0.45 (0.61%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$74.89

0.52 (0.70%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$116.98

1.5 (1.30%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$59.68

0.065 (0.11%)

08:19
09/19/18
09/19
08:19
09/19/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.37

-0.11 (-0.20%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.72

-0.25 (-0.45%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$86.82

0.58 (0.67%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Recommendations
Skyworks analyst commentary  »

Skyworks underperformance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$93.71

0.5 (0.54%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIVB

Civista Bancshares

$22.95

-0.23 (-0.99%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Upgrade
Civista Bancshares rating change  »

Civista Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$170.24

0.68 (0.40%)

08:18
09/19/18
09/19
08:18
09/19/18
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$262.87

1.89 (0.72%)

08:17
09/19/18
09/19
08:17
09/19/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.